To determine whether 3-BP or/and doxorubicin could affect tumor cells mediated pericyte’s glycolytic change, we examined the effect of conditioned medium harvested from cancer cells pre-treated with 3-BP or/and doxorubicin on pericyte-HK2 and ROCK2 expression. The gene discussed is ROCK2; the disease is neoplasm.